REQUEST A DEMO
Total
USD $0.00
Search more companies

Asia Medi Science Company Limited (Thailand)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Asia Medi Science Company Limited Profile Updated: October 18, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Asia Medi Science Company Limited is based in Thailand. The head office is in Ubon Ratchathani. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The enterprise was incorporated on October 28, 2026. 20 (estimated) employees currently work for Asia Medi Science Company Limited. The company’s latest financial report indicates a net sales revenue increase of 19.91% in 2025. Its’ total assets recorded a negative growth of 17.11%. The net profit margin of Asia Medi Science Company Limited increased by 0.65% in 2025.

Headquarters
88/36 Moo 1 Tha Bo Tai (The River Project) Village
Ubon Ratchathani; North-Eastern Thailand; Postal Code: 34000

Contact Details: Purchase the Asia Medi Science Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Asia Medi Science Company Limited report to view the information.
Financial Auditors:
Purchase the Asia Medi Science Company Limited report to view the information.
Incorporation Date:
October 28, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Asia Medi Science Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
19.91%▲
Total Operating Revenue
19.88%▲
Operating Profit
45.73%▲
Net Profit/Loss for the Period
54.81%▲
Total Assets
-17.11%▼
Total Equity
-4.06%▼
Operating Profit Margin
1.33%▲
Net Profit Margin
0.65%▲
Return on Equity (ROE)
8.29%▲
Debt / Equity
-43.81%▼
Quick Ratio
-0.68%▼
Cash Ratio
-0.78%▼

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?